2 news items
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
FATE
2 Apr 24
shares of its common stock to one newly-hired non-executive employee. The grant was approved by the Compensation Committee of the Company's Board
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
FATE
5 Mar 24
to patients with cancer and autoimmune disorders, today announced that the Company granted a non-qualified stock option to one newly-hired employee
- Prev
- 1
- Next